isothiuronium has been researched along with Myocardial Infarction in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lishmanov, YB; Maslov, LN; Naryzhnaya, NV; Prokudina, ES; Tsibulnikov, SY | 1 |
| Jiang, X; Nakajima, Y; Sato, S; Shi, E | 2 |
| Cao, LS; Li, DZ; Liao, YH; Wang, X; Zeng, QT; Zheng, B | 1 |
| Cutini, GJ; Paigel, AS; Pinto, VD; Sartório, CL; Stefanon, I; Vassallo, DV | 1 |
| Bing, RJ; Dudek, RR; Suzuki, H; Wildhirt, SM | 1 |
| Akiyama, K; Bing, RJ; Cannavino, C; Grant, P; Horstman, D; Suzuki, H; Wolf, WP | 1 |
| Dudek, R; Horstman, D; Reichart, B; Suzuki, H; Weismueller, S; Wildhirt, SM; Wolf, WP | 1 |
| Akiyama, K; Dudek, RR; Horstman, D; Reichart, B; Suzuki, H; Weismüller, S; Wildhirt, SM | 1 |
| Carretero, OA; LaPointe, MC; Liu, YH; Wang, D; Yang, XP | 1 |
| Hess, ML; Jarrett, NC; Kukreja, RC; Xi, L | 1 |
| Jarrett, NC; Kukreja, RC; Salloum, F; Tekin, D; Xi, L | 1 |
| Chelliah, J; Kukreja, RC; Levasseur, JE; Xi, L; Zhao, T | 1 |
| Kukreja, RC; Xi, L | 1 |
| Fahas, L; Giaid, A; Hu, F; Saito, T; Shennib, H; Tayara, L | 1 |
2 review(s) available for isothiuronium and Myocardial Infarction
| Article | Year |
|---|---|
Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction.
Topics: Animals; Apoptosis; Coronary Circulation; Enzyme Induction; Enzyme Inhibitors; Humans; Immunohistochemistry; Inflammation; Isothiuronium; Macrophages; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Rabbits; Ventricular Function, Left | 1995 |
Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction.
Topics: Adjuvants, Immunologic; Animals; Enzyme Inhibitors; Glycolipids; Humans; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isothiuronium; Lipid A; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Perfusion; Rats; Signal Transduction | 2000 |
13 other study(ies) available for isothiuronium and Myocardial Infarction
| Article | Year |
|---|---|
[INVOLVEMENT OF NO-SYNTHASE IN THE INFARCT REDUCING EFFECT OF CONTINUOUS CHRONIC NORMOBARTC HYPOXTA].
Topics: Animals; Hypoxia; Ischemic Preconditioning, Myocardial; Isothiuronium; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Rats; Rats, Wistar | 2015 |
Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice.
Topics: Analgesics, Opioid; Animals; Blotting, Western; Coronary Vessels; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Hemodynamics; Isothiuronium; Male; Mice; Mice, Knockout; Morphine; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III | 2004 |
Inhibition of NOS2 ameliorates cardiac remodeling, improves heart function after myocardial infarction in rats.
Topics: Animals; Blotting, Western; Enzyme Inhibitors; Isothiuronium; Ligation; Male; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Time Factors; Ventricular Remodeling | 2004 |
COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cardiotonic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease Models, Animal; Heart; Ischemic Preconditioning, Myocardial; Isothiuronium; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Morphine; Myocardial Infarction; Myocardium; Nitric Oxide Synthase Type II; Nitrobenzenes; Sulfonamides; Up-Regulation | 2006 |
Enhanced beta-adrenergic response in rat papillary muscle by inhibition of inducible nitric oxide synthase after myocardial infarction.
Topics: Adrenergic beta-Agonists; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoproterenol; Isothiuronium; Male; Myocardial Contraction; Myocardial Infarction; Nitric Oxide Synthase Type II; Papillary Muscles; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Ventricular Dysfunction, Left | 2007 |
Effect of inhibitors of inducible form of nitric oxide synthase in infarcted heart muscle.
Topics: Animals; Arginine; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Heart; Isothiuronium; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitroarginine; Rabbits | 1996 |
S-methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Enzyme Induction; Enzyme Inhibitors; Heart Rate; Heart Ventricles; Isoenzymes; Isothiuronium; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitroarginine; Rabbits; Vascular Resistance; Ventricular Function, Left | 1996 |
Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction.
Topics: Animals; Coronary Circulation; Cyclic GMP; Enzyme Induction; Enzyme Inhibitors; Hemodynamics; Isothiuronium; Male; Myocardial Infarction; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rabbits; Ventricular Function, Left | 1997 |
Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase.
Topics: Animals; Animals, Newborn; Blotting, Northern; Blotting, Western; Cell Death; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Follow-Up Studies; Guanidines; Heart; Interleukin-1; Isothiuronium; Male; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1999 |
Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice.
Topics: Animals; Body Weight; Cardiotonic Agents; Coronary Circulation; Enzyme Inhibitors; Heart Rate; Hemodynamics; In Vitro Techniques; Isothiuronium; Lipid A; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Organ Size; Ventricular Function | 1999 |
Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice.
Topics: Animals; Cardiotonic Agents; Enzyme Inhibitors; Glycolipids; Hemodynamics; Ischemic Preconditioning; Isothiuronium; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide Synthase; Nitric Oxide Synthase Type II | 1999 |
Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.
Topics: Adenosine; Animals; Enzyme Inhibitors; Female; Heart; Ischemic Preconditioning, Myocardial; Isothiuronium; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Ventricular Function, Left | 2000 |
Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure.
Topics: Animals; Blotting, Western; Coronary Vessels; Disease Models, Animal; Enzyme Inhibitors; Heart Failure; Immunohistochemistry; Isothiuronium; Ligation; Male; Myocardial Infarction; Myocardium; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Rats; Rats, Inbred Lew; Survival Rate; Treatment Outcome | 2002 |